AIS 5G Supports The 74th Miss Universe 2025 — Welcomes Global Contestants with Special SIM Packages

BANGKOK, Nov. 07, 2025 (GLOBE NEWSWIRE) — AIS 5G, Thailand's No.1 Network, Empowers Miss Universe 2025 to Shine on the Global Stage AIS 5G, the nation's leading intelligent digital network, proudly joins as a key supporter of the The 74th Miss Universe 2025 competition — a world-class pageant that showcases beauty, confidence, and cultural diversity […]

National Center for Civil and Human Rights Reopens With Major Expansion and New Galleries

On Nov. 8, the Center Opens Its Doors for a Community Celebration With Music, Family Fun and Interactive Tours. Be Part of History as the Museum Reopens to the World. ATLANTA, GEORGIA / ACCESS Newswire / November 7, 2025 / The National Center for Civil and Human Rights has reopened following a $57.9 million expansion

Class Action Filed Against RCI Hospitality Holdings, Inc. (RICK) Over Securities Violations – Contact Levi & Korsinsky Today

NEW YORK, NY / ACCESS Newswire / November 7, 2025 / If you suffered a loss on your RCI Hospitality Holdings, Inc. (NASDAQ:RICK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/rci-hospitality-holdings-inc-lawsuit-submission-form?prid=176060&wire=1&utm_campaign=29 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com

Barrick Completes Sale of Alturas Project

(TSX:ABX),(NYSE:B),(LSE:0R22), All amounts expressed in U.S. dollars TORONTO, Nov. 07, 2025 (GLOBE NEWSWIRE) — Barrick Mining Corporation (NYSE:B)(TSX:ABX) (“Barrick” or the “Company”) announced today that it has completed the divestiture of the Alturas Project (the “Project”) in Chile to Boroo Pte. Ltd (Singapore) for an up-front cash payment of $50 million. In addition, Barrick has

Barrick Completes Sale of Alturas Project

Barrick Completes Sale of Alturas Project GlobeNewswire November 07, 2025 All amounts expressed in U.S. dollars TORONTO, Nov. 07, 2025 (GLOBE NEWSWIRE) — Barrick Mining Corporation (NYSE:B)(TSX:ABX) (“Barrick” or the “Company”) announced today that it has completed the divestiture of the Alturas Project (the “Project”) in Chile to Boroo Pte. Ltd (Singapore) for an up-front

Levi & Korsinsky Urges Fortinet, Inc. (FTNT) Shareholders to Act Before Lead Plaintiff Deadline November 21, 2025

NEW YORK, NY / ACCESS Newswire / November 7, 2025 / If you suffered a loss on your Fortinet, Inc. (NASDAQ:FTNT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/fortinet-inc-lawsuit-submission-form?prid=176058&wire=1&utm_campaign=19 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Join Class Action to Recover Losses from WPP plc (WPP) – Contact Levi & Korsinsky Before December 8, 2025

NEW YORK, NY / ACCESS Newswire / November 7, 2025 / If you suffered a loss on your WPP plc (NYSE:WPP) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/wpp-plc-lawsuit-submission-form?prid=176059&wire=1&utm_campaign=31 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Rhythm Pharmaceuticals Announces FDA Extension of Review Period for IMCIVREE(R) (setmelanotide) for Patients with Acquired Hypothalamic Obesity

(NasdaqGM:RYTM), — FDA sets updated PDUFA goal date of March 20, 2026 – — Company to hold conference today at 8:00 a.m. — BOSTON, Nov. 07, 2025 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that

Barinthus Bio Reports Third Quarter 2025 Financial Results and Updates on Corporate Developments

(NasdaqGM:BRNS), Single ascending dose data readout for VTP-1000 expected before the end of 2025 Enrollment advancing in multiple ascending dose part of the AVALON trial; data expected in the second half of 2026 Proposed combination with Clywedog Therapeutics Inc. (“Clywedog”) to strengthen and diversify the pipeline and broaden the Company's base of high caliber institutional

Scroll to Top